BioSpace News Archive

Dr. Mahony brings more than three decades of broad cross-functional and global experience to the board.

Employee Satisfaction Contributes to Nihon Kohden’s Success as Fastest-Growing Company in Patient Monitoring Segment

Chief Executive Officer Edward M. Kaye, M.D., will participate in a fireside chat at the Canaccord Genuity 39th Annual Growth Conference on Thursday, August 8, 2019 at 9:00 a.m. ET in Boston, Mass.

I-Mab entered into a research collaboration with Roche in April 2019 where Roche agreed to supply TECENTRIQ® to I-Mab for use in clinical study in combination with TJD5.

Early on in her 18 years at SHS, patients needing physical therapy began requesting her by name.

Provides intelligent subsystem capability for demanding laser-based applications

Axonics Modulation Technologies, Inc. announced completion of 1-year follow-ups and top-line clinical results from its ARTISAN-SNM pivotal clinical study conducted under an U.S. Food & Drug Administration Investigational Device Exemption designed to evaluate the safety and efficacy of the Axonics r-SNM® System1.

Kyowa Kirin Co., Ltd., and AVEO Oncology announce that they have amended their license agreement to allow Kyowa Kirin to buy back the non-oncology rights of tivozanib in AVEO territories, which includes the U.S. and EU.

IDEXX Laboratories, Inc., a global leader in veterinary diagnostics, veterinary practice software and water microbiology testing, reports revenues of $620 million for the second quarter of 2019, an increase of 7% compared to the prior year period on a reported basis, and 9% on an organic basis.

NantHealth, Inc., a next-generation, evidence-based, personalized healthcare company, announced that it will report financial results for its 2019 second quarter on Thursday, August 8, 2019, after market close.